ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1987 • 2014 ACR/ARHP Annual Meeting

    Simulation in Continuing Education: Improving Evidence-Based Decisions for Rheumatoid Arthritis Management

    Nimish Mehta1, Martin Warters2 and Douglas Blevins2, 1Medscape, LLC, New York, NY, 2Therasim, Durham, NC

    Background/Purpose In many patients with rheumatoid arthritis (RA), the disease is not adequately controlled, and only a minority of patients attain the goal of consistent…
  • Abstract Number: 1984 • 2014 ACR/ARHP Annual Meeting

    Implementation and Performance of an Objective Structured Clinical Examination (OSCE) in a National Certification Process of Trainees in Rheumatology. Two Years of Experience

    Virginia Pascual Ramos1, Gabriel Medrano-Ramírez1, Eunice Solis-Vallejo1, Ana Bernard-Medina2, Diana Flores1, Margarita Portela Hernandez1, Lilia Andrade-Ortega1, Olga Lidia Vera-Lastra1, Rolando Espinosa-Morales1, Juan Miranda-Limón1, M Maldonado-Velázquez1, Luis Javier Jara3, Luis M. Amezcua-Guerra1, Judith Lopez-Zepeda1, Miguel Angel Saavedra1 and Cesar Alejandro Arce1, 1Mexican Board of Rheumatology, Mexico City, Mexico, 2Reumatologia, Antiguo Hospital Civil de Guadalajara - Fray Antonio Alcalde, Mexico City, Mexico, 3Hospital de Especialidades. Centro Médico La Raza, IMSS, Mexico City, Mexico

    Background/Purpose We developed and conducted an OSCE to assess clinical skills of trainees in rheumatology (TRs) and determine its performance at two consecutive annual evaluations…
  • Abstract Number: 1983 • 2014 ACR/ARHP Annual Meeting

    Improving Resident Confidence with the Musculoskeletal Exam through a Rheumatology-Dedicated Musculoskeletal Workshop

    Kimberly Fisher1, Alexa Meara2, Brian LaMoreaux3, Hareth Madhoun4, Irving Rosenberg5, Xiaokui Mo6, Lisa G. Criscione-Schreiber7 and Nicole Bundy8, 1Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, 2Internal Medicine/Rheumatology, The Ohio State University, Columbus, OH, 3Dept of Internal Medicine, Division of Rheumatology, The Ohio State University, Columbus, OH, 4Rheumatology/Immunology, The Ohio State University Wexner Medical Center, Columbus, OH, 5Rheumatology, The Ohio State University, Columbus, OH, 6Center for Biostatistics, The Ohio State University Wexner Medical Center, Columbus, OH, 7Rheumatology, Duke University Health System, Durham, NC, 8Internal Medicine - Rheumatlogy, OSU Medical Center, Columbus, OH

    Background/Purpose Musculoskeletal (MSK) complaints are among the most common complaints evaluated by primary care physicians. Thus, it is imperative that Internal Medicine (IM) residents learn…
  • Abstract Number: 1981 • 2014 ACR/ARHP Annual Meeting

    A Qualitative Analysis of Methotrexate Injection Videos on Youtube

    Rebekah Rittberg1, Tharindri Dissanayake2 and Steven J. Katz3, 1University of Manitoba, Winnipeg, MB, Canada, 2Medicine, University of Alberta, Edmonton, AB, Canada, 3Rheumatology, University of Alberta, Edmonton, AB, Canada

    Background/Purpose: Methotrexate (MTX) is one of the most commonly prescribed disease modifying antirheumatic drugs for rheumatoid arthritis. While data suggests subcutaneously administered methotrexate is more…
  • Abstract Number: 1980 • 2014 ACR/ARHP Annual Meeting

    Thrombospondin-1 Is Elevetad in the Plasma of Patients with Antiphospholipid Syndrome and Is Correlated with Soluble Fas Ligand and Free Active TGF-B levels

    Markos Patsouras1, Marina Sikara2, Athanasios G. Tzioufas2 and Panayiotis Vlachoyiannopoulos2, 1PATHOPHYSIOLOGY DEPARTMENT, UNIVERSITY OF ATHENS, School of Medicine, National University of Athens, Athens, Greece, 2Pathophysiology, School of Medicine, National University of Athens, Athens, Greece

    Background/Purpose Antiphospholipid syndrome (APS) is an acquired thombophillia characterized by recurrent thromboembolism and pregnancy morbidity. Thrombospondin (TSP-1) is a matricellular glycoprotein with antiangiogenic and proapoptotic…
  • Abstract Number: 1979 • 2014 ACR/ARHP Annual Meeting

    Pseudostarvation By AMPK Activator Therapy Is Associated with Reduced Disease Activity and Downregulation of Pro-Inflammatory Responses in Rheumatoid Arthritis (RA)

    Lorna Gallagher1, Ursula Fearon2, Douglas J. Veale3, David Kane1, Luke A. O'Neill4 and Ronan Mullan1, 1Department of Rheumatology, Tallaght Hospital, TCD, Dublin 24, Ireland, 2Dublin Academic Medical Centre, Translational Rheumatology Research Group, Dublin, Ireland, 3Translational Rheumatology Research Group, St. Vincent's University Hospital, Dublin 4, Ireland, 4Inflammation Research, School of Biochemistry and Immunology, Dublin, Ireland

    Background/Purpose AMP-activated protein kinase (AMPK) is a highly conserved, regulator of cellular energy status. In inflammation, AMPK inactivation is associated with increased glucose consumption through…
  • Abstract Number: 1977 • 2014 ACR/ARHP Annual Meeting

    The Proangiogenic Function of the Epigenetic Regulator EZH2 in Synovial Tissue Is Mediated By Fibroblasts in Rheumatoid Arthritis

    Michelle Trenkmann1, Steffen Gay2, Douglas J. Veale1 and Ursula Fearon1, 1Dublin Academic Medical Centre, Translational Rheumatology Research Group, Dublin, Ireland, 2Center of Experimental Rheumatology, University Hospital Zurich, Zurich, Switzerland

    Background/Purpose The histone methyltransferase Enhancer of Zeste 2 (EZH2) is overexpressed in solid tumors and is associated with invasion, malignancy and tumor angiogenesis. EZH2 expression…
  • Abstract Number: 1976 • 2014 ACR/ARHP Annual Meeting

    Elevation and Functional Activity of Interferon Omega in Human Systemic Lupus Erythematosus

    Jarrat Jordan1, Jessica Schreiter1, Hao Liu2, Sreedevi Adhikarakunnathu2, Chichi Huang3 and Jacqueline Benson1, 1Estrela Lupus Venture, Janssen Research and Development, LLC., Spring House, PA, 2Immunology Research, Janssen Research and Development, LLC., Spring House, PA, 3Biologics Research, Janssen Research and Development, LLC., Spring House, PA

    Background/Purpose IFNα is emerging as a clinically validated target in SLE yet it is currently unclear if other type I IFNs are contributing to the…
  • Abstract Number: 1975 • 2014 ACR/ARHP Annual Meeting

    Profiling 14-3-3η in Human Primary Cell Based BioMAP® Disease Models Reveals a Unique Pro-Inflammatory Phenotypic Signature Consistent with RA-Inflammation Biology

    Alison O'Mahony1, Ellen L. Berg1, Walter P. Maksymowych2, Yuan Gui3 and Anthony Marotta4, 1BioSeek, South San Francisco, CA, 2Department of Medicine, University of Alberta, Edmonton, AB, Canada, 3Augurex Life Sciences Corp., North Vancouver, BC, Canada, 41423 Dempsey Road, Augurex Life Sciences Corp., North Vancouver, BC, Canada

    Background/Purpose 14-3-3 proteins represent a highly conserved seven-member family of ubiquitously expressed intracellular chaperonins that perform a broad range of signaling functions.  The 14-3-3 eta…
  • Abstract Number: 1974 • 2014 ACR/ARHP Annual Meeting

    Sex Steroids, Interleukin-1, and Interleukin-10 Inhibit interferon–gamma (IFN-γ) Induced B Cell Activating Factor of the Tumor Necrosis Factor Family (BAFF) in Human Synovial Fibroblasts

    Georg Pongratz1, Marina Bäuml2, Tanja Späth2, Rainer Straub3 and Torsten Lowin2, 1Internal Medicine I, University Hospital Regensburg, Regensburg, Germany, 2University Hospital Regensburg, Regensburg, Germany, 3Internal Medicine, University Hospital Regensburg, Regensburg, Germany

    Background/Purpose B cell activating factor of the tumor necrosis factor family (BAFF) is a cytokine important for the stimulation and survival of autoreactive B cells…
  • Abstract Number: 1973 • 2014 ACR/ARHP Annual Meeting

    Ectopic Lymphoid Neogenesis Is Strongly Associated with Activation of the IL-23/IL-17 Pathway in Rheumatoid Synovitis

    Nataliya Yeremenko1, Raquel Celis2, Leonie M. van Duivenvoorde3, Julio Ramirez4, Iris C. Blijdorp5, Sara Marsal6, Jose L. Pablos7, Raimon Sanmarti4, Juan D. Cañete4 and Dominique L. Baeten1, 1Department of Clinical Immunology and Rheumatology and Department of Experimental Immunology, Academic Medical Centre/University of Amsterdam, Amsterdam, Netherlands, 2Arthritis Unit, Rheumatology Department, Arthritis Unit, Rheumatology Dpt, Hospital Clinic of Barcelona and IDIBAPS, Barcelona, Spain, 3Experimental Immunology, Department of Clinical Immunology and Rheumatology and Department of Experimental Immunology, Academic Medical Centre/University of Amsterdam, Amsterdam, Netherlands, 4Arthritis Unit. Rheumatology Department, Hospital Clínic of Barcelona, Barcelona, Spain, 5Department of Clinical Immunology & Rheumatology, Department of Clinical Immunology and Rheumatology and Department of Experimental Immunology, Academic Medical Centre/University of Amsterdam, Amsterdam, Netherlands, 6Rheumatology Research Group, Vall d'Hebron Hospital Research Institute, Barcelona, Spain, 7Servicio de Reumatología, Instituto de Investigación Hospital 12 de Octubre (I+12), Madrid, Spain

    Background/Purpose : The functional relevance of synovial ectopic lymphoid neogenesis (ELN) in rheumatoid arthritis (RA) remains unknown. As ELN correlates with the degree of tissue…
  • Abstract Number: 1972 • 2014 ACR/ARHP Annual Meeting

    Analysis of Anakinra in Primary Human Cell Systems Reveals an in Vitro Signature for Skin-Related Side Effects

    Ellen L. Berg, Alison O'Mahony and Mark A Polokoff, BioSeek, South San Francisco, CA

    Background/Purpose The therapeutic options for treatment of rheumatic diseases have grown and now include a variety of inflammatory pathway inhibitors, with diverse mechanisms, but having…
  • Abstract Number: 1971 • 2014 ACR/ARHP Annual Meeting

    The Role of the Proinflammatory Mediator High-Mobility Group Box Protein 1 (HMGB1) in Anti-Collagen-Antibody-Induced Arthritis Is Dependent on Vascular Endothelial Growth Factor (VEGF)

    Federico Biscetti1, Andrea Flex2, Giovanni Pecorini2, Flavia Angelini2, Vincenzo Arena3, Egidio Stigliano3, Barbara Tolusso1, Elisa Gremese1 and Gianfranco Ferraccioli1, 1Division of Rheumatology, Institute of Rheumatology and Affine Sciences, Catholic University of the Sacred Heart, Rome, Italy, 2Laboratory of Vascular Biology and Genetics, Catholic University School of Medicine, Rome, Italy, 3Department of Pathology, Catholic University School of Medicine, Rome, Italy

    Background/Purpose High-mobility group box 1 (HMGB1) is a non-histone nuclear protein that is released extracellulary and has been implicated in rheumatoid arthritis (RA) and angiogenesis.…
  • Abstract Number: 1970 • 2014 ACR/ARHP Annual Meeting

    TH17 Inflammatory Responses Occur in a Subset of Patients with Erythema Migrans or Lyme Arthritis, but Are Not Predominant Responses in Joints

    Klemen Strle1, Elise E. Drouin1 and Allen C. Steere2, 1Medicine, Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 2Medicine, Center for Immunolgy and Inflammatory Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, MA

    Background/Purpose Lyme disease usually begins with an expanding skin lesion, erythema migrans (EM), whereas arthritis is a late disease manifestation. The infection usually resolves with…
  • Abstract Number: 1969 • 2014 ACR/ARHP Annual Meeting

    Neurotrophin Receptor p75 (CD271) Defines a Distinct Synovial Fibroblast Subset in Rheumatoid and Osteoarthritic Synovial Tissues with Enhanced Proinflammatory Potential

    Manuel J. Del Rey1, Regina Faré1, Gabriel Criado2, Alicia Usategui1, Vanessa Miranda1, Juan D. Cañete3 and Jose L. Pablos1, 1Servicio de Reumatología, Instituto de Investigación Hospital 12 de Octubre (I+12), Madrid, Spain, 2Grupo de Enfermedades Inflamatorias y Autoinmunes, Instituto de Investigación Hospital 12 de Octubre (I+12), Madrid, Spain, 3Arthritis Unit. Rheumatology Department, Hospital Clínic of Barcelona, Barcelona, Spain

    Background/Purpose Synovial mesenchynmal or stromal cells constitute a heterogeneous cell population difficult to characterize ex vivo due to a paucity of cell markers and are…
  • « Previous Page
  • 1
  • …
  • 1918
  • 1919
  • 1920
  • 1921
  • 1922
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology